The Mendelian Society of Lund has been publishing the journal Hereditas since 1920.
Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy
Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ERα+) breast cancer. However, about 40% of patients with ERα + breast cancer who receive tamoxifen therapy eventually develop r...
Citation: Hereditas 2018 155:17